Literature DB >> 17260964

Inhibition of complex I by Ca2+ reduces electron transport activity and the rate of superoxide anion production in cardiac submitochondrial particles.

Satoshi Matsuzaki1, Luke I Szweda.   

Abstract

Declines in the rate of mitochondrial electron transport and subsequent increases in the half-life of reduced components of the electron transport chain can stimulate O2*- formation. We have previously shown that, in solubilized cardiac mitochondria, Ca2+ mediates reversible free radical-induced inhibition of complex I. In the study presented here, submitochondrial particles prepared from rat heart were utilized to determine the effects of Ca2+ on specific components of the respiratory chain and on the rates of electron transport and O2*- production. The results indicate that complex I is inactivated when submitochondrial particles are treated with Ca2+. Inactivation was specific to complex I with no alterations in the activities of other electron transport chain complexes. Complex I inactivation by Ca2+ resulted in the reduction of NADH-supported electron transport activity. In contrast to the majority of electron transport chain inhibitors, Ca2+ suppressed the rate of O2*- production. In addition, while inhibition of complex III stimulated O2*- production, Ca2+ reduced the relative rate of O2*- production, consistent with the magnitude of complex I inhibition. Evidence indicates that complex I is the primary source of O2*- released from this preparation of submitochondrial particles. Ca2+ therefore inhibits electron transport upstream of site(s) of free radical production. This may represent a means of limiting O2*- production by a compromised electron transport chain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17260964     DOI: 10.1021/bi0617916

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Age-dependent dystrophin loss and genetic reconstitution establish a molecular link between dystrophin and heart performance during aging.

Authors:  DeWayne Townsend; Michael Daly; Jeffrey S Chamberlain; Joseph M Metzger
Journal:  Mol Ther       Date:  2011-07-05       Impact factor: 11.454

Review 2.  OXPHOS mutations and neurodegeneration.

Authors:  Werner J H Koopman; Felix Distelmaier; Jan A M Smeitink; Peter H G M Willems
Journal:  EMBO J       Date:  2012-11-13       Impact factor: 11.598

3.  L-arginine is a radioprotector for hematopoietic progenitor cells.

Authors:  Linda L Pearce; Xichen Zheng; Sandra Martinez-Bosch; Patrick P Kerr; Pornsri Khlangwiset; Michael W Epperly; Mitchell P Fink; Joel S Greenberger; Jim Peterson
Journal:  Radiat Res       Date:  2011-12-16       Impact factor: 2.841

4.  TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction.

Authors:  Nithya Mariappan; Carrie M Elks; Bruno Fink; Joseph Francis
Journal:  Free Radic Biol Med       Date:  2008-11-12       Impact factor: 7.376

5.  Mitochondrial superoxide production and respiratory activity: biphasic response to ischemic duration.

Authors:  Satoshi Matsuzaki; Luke I Szweda; Kenneth M Humphries
Journal:  Arch Biochem Biophys       Date:  2009-01-14       Impact factor: 4.013

6.  Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI).

Authors:  Xichun Yu; Yasvir A Tesiram; Rheal A Towner; Andrew Abbott; Eugene Patterson; Shijun Huang; Marion W Garrett; Suresh Chandrasekaran; Satoshi Matsuzaki; Luke I Szweda; Brian E Gordon; David C Kem
Journal:  Cardiovasc Diabetol       Date:  2007-02-19       Impact factor: 9.951

7.  Substrate- and Calcium-Dependent Differential Regulation of Mitochondrial Oxidative Phosphorylation and Energy Production in the Heart and Kidney.

Authors:  Xiao Zhang; Namrata Tomar; Sunil M Kandel; Said H Audi; Allen W Cowley; Ranjan K Dash
Journal:  Cells       Date:  2021-12-31       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.